To view a copy of this licence, visit About this article Cite this article Yepes-Corts, C.A., Cardenas-Moreno, I.C., Daza-Arnedo, R
In general, GLP-1 agonists promote weight loss through the following two mechanisms: Suppression of appetite and cravings: These medications target the brain to curtail appetite so one can achieve satiety with small portions of food
For instance, if your condition impairs your ability to absorb nutrients, like Crohns disease or celiac disease, your doctor might prescribe IV therapy as a necessary treatment
This can lead to a temporary dip in immune function and slower recovery times
N Engl J Med 324:11491155 Convention USP (2007) The United States Pharmacopeia, (USP) 30